Evidence map›Paper›PMID 33990468›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

AP-3-dependent targeting of flippase ATP8A1 to lamellar bodies suppresses activation of YAP in alveolar epithelial type 2 cells.

Seunghyi Kook, Ping Wang, Shufang Meng, Christopher S Jetter, Jennifer M S Sucre, John T Benjamin, Jason J Gokey, Hayley A Hanby, Alexa Jaume, Laura Goetzl and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Seunghyi KookDepartment of Pediatrics, Division of Neonatology, Vanderbilt University Medical Center, Nashville, TN 37232.ORCID 0000-0002-4153-0601
Ping WangDepartment of Pediatrics, Division of Neonatology, Vanderbilt University Medical Center, Nashville, TN 37232.
Shufang MengDepartment of Pediatrics, Division of Neonatology, Vanderbilt University Medical Center, Nashville, TN 37232.
Christopher S JetterDepartment of Pediatrics, Division of Neonatology, Vanderbilt University Medical Center, Nashville, TN 37232.
Jennifer M S SucreDepartment of Pediatrics, Division of Neonatology, Vanderbilt University Medical Center, Nashville, TN 37232.
John T BenjaminDepartment of Pediatrics, Division of Neonatology, Vanderbilt University Medical Center, Nashville, TN 37232.ORCID 0000-0002-0930-1753
Jason J GokeyDepartment of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN 37232.
Hayley A HanbyDepartment of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA 19104.
Alexa JaumeDepartment of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA 19104.
Laura GoetzlDepartment of Obstetrics, Gynecology, and Reproductive Sciences, McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX 77030.
Michael S MarksDepartment of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA 19104.ORCID 0000-0001-7435-7262
Susan H GuttentagDepartment of Pediatrics, Division of Neonatology, Vanderbilt University Medical Center, Nashville, TN 37232; susan.guttentag@vumc.org.ORCID 0000-0003-4420-5879
Vanderbilt University Medical Center · USChildren's Hospital of Philadelphia · USThe University of Texas Health Science Center at Houston · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI STACIE B DUSETZINA · 1995 to 2026
$172.8M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ALVIN C POWERS · 2012 to 2026
$29.3M
Shop Module CoreP30EY008126 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI David J. Calkins · 1989 to 2026
$19.6M
Vanderbilt Mouse Metabolic Physiology CenterU24DK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2001 to 2015
$14.9M
Hermansky Pudlak Syndrome &melanosome formationR01EY015625 · NEI · UNIVERSITY OF PENNSYLVANIA · PI Michael S Marks · 2004 to 2026
$9.2M
Metabolic reprogramming of Alveolar Type 2 cells in response to lung injuryR01HL150617 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI GUTTENTAG, SUSAN H. · 2022 to 2025
$2.4M
Lamellar Body Biogenesis in Health and DiseaseR01GM108807 · NIGMS · CHILDREN'S HOSP OF PHILADELPHIA · PI GUTTENTAG, SUSAN H., MARKS, MICHAEL S · 2014 to 2017
$1.5M
Regulation of Elastin Assembly during Saccular Stage Lung DevelopmentK08HL133484 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BENJAMIN, JOHN · 2017 to 2021
$739k
Wnt Signaling in Bronchopulmonary DysplasiaK08HL143051 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SUCRE, JENNIFER MALCOLMSRYGLEY · 2019 to 2023
$698k
Leica Bond RXS10OD023475 · OD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BOYD, KELLI L. · 2018 to 2018
$213k
NCI NIH HHS P30 CA068485NEI NIH HHS P30 EY008126NEI NIH HHS R01 EY015625NHLBI NIH HHS K08 HL133484NHLBI NIH HHS K08 HL143051NHLBI NIH HHS R01 HL150617NIDDK NIH HHS P30 DK020593NIDDK NIH HHS P30 DK058404NIDDK NIH HHS U24 DK059637NIGMS NIH HHS R01 GM108807NIH HHS S10 OD023475
6 · The paper itself

Abstract

Lamellar bodies (LBs) are lysosome-related organelles (LROs) of surfactant-producing alveolar type 2 (AT2) cells of the distal lung epithelium. Trafficking pathways to LBs have been understudied but are likely critical to AT2 cell homeostasis given associations between genetic defects of endosome to LRO trafficking and pulmonary fibrosis in Hermansky Pudlak syndrome (HPS). Our prior studies uncovered a role for AP-3, defective in HPS type 2, in trafficking Peroxiredoxin-6 to LBs. We now show that the P4-type ATPase ATP8A1 is sorted by AP-3 from early endosomes to LBs through recognition of a C-terminal dileucine-based signal. Disruption of the AP-3/ATP8A1 interaction causes ATP8A1 accumulation in early sorting and/or recycling endosomes, enhancing phosphatidylserine exposure on the cytosolic leaflet. This in turn promotes activation of Yes-activating protein, a transcriptional coactivator, augmenting cell migration and AT2 cell numbers. Together, these studies illuminate a mechanism whereby loss of AP-3-mediated trafficking contributes to a toxic gain-of-function that results in enhanced and sustained activation of a repair pathway associated with pulmonary fibrosis.

Indexed as

Adaptor Protein Complex 3Adaptor Proteins, Signal TransducingAdenosine TriphosphatasesAlveolar Epithelial CellsAnimalsBiological TransportCell LineCell MovementDisease Models, AnimalEndosomesFemaleGene Expression RegulationHermanski-Pudlak SyndromeHumansLungLysosomesAdaptor Protein Complex 3Adaptor Proteins, Signal TransducingAdenosine TriphosphatasesATP8A1 protein, humanPeroxiredoxin VIPhosphatidylserinesPhospholipid Transfer Proteinsrab11 GTP-Binding Proteinsrab GTP-Binding ProteinsTranscription FactorsYAP1 protein, humanYAP-Signaling Proteinsendosomelung epitheliumlysosomepulmonary fibrosis

Identifiers

PMID33990468
PMCPMC8157957
OpenAlexW3163311140

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.